Previous work regarding the contribution of CD36 and FATP4 to hepatic LCFA uptake as a possible player in NAFLD or NASH found that overexpression of FATP2 and FATP4 in cells was associated with elevated oleate uptake in comparison with control cells. Here, SLC27A4 is linked to metabolic dysfunction-associated steatotic liver disease.